Thoracic Surgery Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, France, China, Japan - Size and Forecast 2024-2028

Published: Nov 2023 Pages: 163 SKU: IRTNTR76770

Thoracic Surgery Market 2024-2028

The global thoracic surgery market size is estimated to grow by USD 18.14 billion at a CAGR of 9.04% between 2023 and 2028. 

The rising prevalence of respiratory diseases has significantly contributed to the growth of the thoracic surgery market. Conditions such as asthma and chronic obstructive pulmonary disease (COPD) affect millions of people worldwide, creating a strong demand for innovative solutions that can improve disease management and enhance patient's quality of life. Respiratory diseases encompass a range of conditions affecting the lungs and airways, such as chronic obstructive pulmonary disease (COPD), asthma, pneumonia, and bronchitis. Moreover, sedentary lifestyles, unhealthy diets, and lack of exercise lead to obesity and metabolic issues that exacerbate respiratory diseases. Moreover, certain occupations expose workers to respiratory hazards, such as dust, chemicals, and fumes, increasing the risk of developing lung conditions. Thus, the rising prevalence of respiratory diseases will drive the growth of the thoracic surgery market during the forecast period.

Technavio has segmented the market into End-user, Product, and Geography 

  • The end-user segment is classified into hospitals, ambulatory surgical centers, and specialty clinics
  • The product segment is classified into CRM and cardiac assist devices, heart valve repair and replacement devices, cardiopulmonary devices, heart defect closure devices, and other thoracic surgery devices
  • The geography segment includes key regions such as North America, Europe, Asia, and Rest of World (ROW)

It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historical data from 2018 - 2022, besides analyzing the current market scenario.

What will be the size of the Thoracic Surgery Market During the Forecast Period?

To learn more about this report, Request Free Sample

Thoracic Surgery Market Segmentation by End-user, Product and Geography Analysis

End-user Analysis 

Hospitals

The market share growth by the hospitals segment will be significant during the forecast period. Hospitals are the major end-users of thoracic surgery devices and occupy most of the market share in the global thoracic surgery devices market by end-users. Hospitals are the preferred choice for treating severe thoracic conditions, such as complicated cardiovascular diseases and advanced-stage lung cancer.

Get a glance at the market contribution of various segments Download PDF Sample

The hospitals segment was the largest and was valued at USD 20.14 billion in 2018. The factors that are driving the growth of the market include the entry of several private hospitals and clinics, the availability of specialized thoracic surgery packages, and the increasing incidence of respiratory diseases. Also, a few key market players are investing in developing effective distribution networks with hospitals to increase their market penetration. Mostly, surgeries that require extensive monitoring, such as thoracic surgery, are performed in hospitals as well as clinics. Furthermore, hospitals have a trained workforce who can operate technologically advanced thoracic surgery devices such as fenestrated forceps, bipolar fenestrated forceps, and other devices. Hence, hospitals are preferred by patients undergoing thoracic surgery. Thus, the hospital segment is expected to register significant growth during the forecast period. This is expected to drive the growth of the hospital end-user segment of the global thoracic surgery market during the forecast period

Product Analysis 

CRM and cardiac assist devices 

Cardiac rhythm management devices (CRM) and cardiac assist devices are mechanical pumps that connect with the heart to raise pumping efficiency and maintain optimal blood flow throughout the body. The CRM devices such as pacemakers, implantable cardioverter-defibrillators, and cardiac assist devices treat end-stage heart failure based on individual demands. The new technologies enable the CRM and cardiac assist devices to advance dramatically, such as incorporating indications for these devices, due to which many patients can be handled with cardiology devices that have exponential therapeutic and monitoring outcomes. Therefore, factors such as the prevalence of heart failure across the globe will result in the increased demand for CRM and cardiac assist devices, propelling the growth of the segment in the global thoracic surgery market during the forecast period.

Regional Analysis

For more insights about the market share of various regions Download PDF Sample now!

Europe is estimated to contribute 35% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. Another region offering significant growth opportunities to companies is North America. North America holds a dominant share of the global thoracic surgery market in 2023. The dominance can be attributed to factors including favourable reimbursement policies, high healthcare expenditure, and the growing prevalence of cardiovascular diseases and disorders. The rising prevalence of lung cancer in the region is one of the major factors driving the growth of the thoracic surgery market in the region. Lung cancer is the third most common cancer in the US, followed by breast cancer (among women) and prostate cancer (among men). For instance, according to the American Cancer Society (ACS), in 2023, lung cancer is expected to account for 12.2% of all new cancer cases and 20.8% of all cancer deaths in 2023.

In addition, the graphical and imagining advancements in medicine, such as three-dimensional thoracoscopy, fluorescence colourization, virtual reality, and augmented reality technologies, have broadened the boundaries of medical procedures to enhance surgical planning, operational precision, and accuracy. Such technological advancements will surge the demand for thoracic surgery in the region as more people opt for these surgeries to treat their respiratory problems. Therefore, all such factors will foster the growth of the thoracic surgery market in the region during the forecast period.

COVID Recovery Analysis

The outbreak of COVID-19 negatively affected the growth of the thoracic surgery market in the region in 2020. However, in 2021, following the widespread COVID-19 vaccination drives, lockdown restrictions in various countries were somewhat lifted, which led to the resumption of business activities and the re-opening of offline retail pharmacies. In addition to that, the COVID-19 pandemic has heightened awareness of respiratory health, potentially leading to increased attention on respiratory care, research, and management. Thus, this is expected to boost the growth of the thoracic surgery market in North America during the forecast period. 

Buy Full Report Now

Key Thoracic Surgery Market Players 

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 15 market companies, including:

Abbott Laboratories - The company offers thoracic surgery products such as Cardiac Rhythm Management catheters and CRT devices.

  • AbbVie Inc.
  • Becton Dickinson and Co.
  • Biosensors International Group Ltd.
  • BioVentrix Inc.
  • Boston Scientific Corp.
  • Cardio Medical GmbH,
  • Edwards Lifesciences Corp.,
  • GE Healthcare Technologies Inc.,
  • Intuitive Surgical Inc.
  • Johnson and Johnson
  • LivaNova Plc
  • Medtronic Plc
  • Richard Wolf GmbH
  • Teleflex Inc.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Thoracic Surgery Market: Key Trends, Challenges, and Customer Landscape

There are multiple factors influencing market growth. Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. 

Significant Thoracic Surgery Market Trends

The emergence of telehealth and remote monitoring is a primary trend shaping the market growth.  The COVID-19 pandemic in 2020 accelerated the adoption of telehealth services, transforming healthcare delivery. Telehealth enables remote consultations, diagnosis, treatment, and monitoring for respiratory patients and cardiac patients, improving access to medical care. Telehealth platforms allow respiratory patients and cardiac patients to consult pulmonologists and other specialists virtually. This is especially beneficial for those who have difficulty traveling or are at higher risk during the pandemic. Telehealth enables healthcare providers to diagnose and assess respiratory conditions and other thoracic conditions remotely, using video consultations, patient histories and shared medical data. 

Moreover, remote monitoring technologies facilitate care delivery at patient's homes. This is essential for individuals with severe respiratory conditions and other thoracic conditions who may need frequent monitoring but are at risk in healthcare settings. Thus, the emergence of telehealth and remote monitoring will promote the growth of the thoracic surgery market during the forecast period. 

Major Thoracic Surgery Market Challenges

Concerns associated with screening and diagnosis of thoracic surgery are a significant challenge hindering the market growth. The concerns associated with the screening and the diagnosis errors fail to establish an accurate and timely explanation of the patient's health problems. The increase in diagnosis errors is recognized as a threat to public health. Any gaps that arise in the diagnostic process restrict the initiation of appropriate and timely treatment to the patient and reduce the chances of optimizing the patient outcome. The challenges associated with screening and diagnosing respiratory diseases include pulmonary arterial hypertension (PAH) and cardiovascular diseases. Without the correct diagnosis, a patient may not receive the appropriate treatment.

Moreover, the major challenge that must be overcome is the late diagnosis of PAH. Symptoms of PAH, such as fatigue, weakness, and breathlessness, overlap with symptoms of other disorders such as COPD and asthma. This can result in the late diagnosis of PAH and may result in the disease progressing to higher stages. Thus, the concerns associated with screening and diagnosis of respiratory diseases and cardiovascular diseases will hinder the growth of the thoracic surgery market during the forecast period.

Buy Now Full Report

Key Thoracic Surgery Market Customer Landscape

The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Global Thoracic Surgery Market Customer Landscape

Segment Overview

The thoracic surgery market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2018 to 2028. 

  • End-user Outlook
    • Hospitals
    • Ambulatory surgical centers
    • Specialty clinics
  • Product Outlook
    • CRM and cardiac assist devices
    • Heart valve repair and replacement devices
    • Cardiopulmonary devices
    • Heart defect closure devices
    • Other thoracic surgery devices
  • Region Outlook
    • North America
      • The U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • France
      • Rest of Europe
    • Asia
      • China
      • India
    • Rest Of World 
      • Brazil
      • Argentina 
      • Australia 

Thoracic Surgery Market Scope

Report Coverage

Details

Page number

163

Base year

2023

Historic period

2018-2022

Forecast period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 9.04%

Market Growth 2024-2028

USD 18.14 billion

Market structure

Fragmented

YoY growth 2023-2024(%)

8.33

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

Europe at 35%

Key countries

US, Germany, France, China, and Japan

Competitive landscape

 Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks

Key companies profiled

Abbott Laboratories, AbbVie Inc., Becton Dickinson and Co., Biosensors International Group Ltd., BioVentrix Inc., Boston Scientific Corp., Cardio Medical GmbH, Edwards Lifesciences Corp., GE Healthcare Technologies Inc., Intuitive Surgical Inc., Johnson and Johnson, LivaNova Plc, Medtronic Plc, Richard Wolf GmbH, and Teleflex Inc.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period. 

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Download Sample PDF at your Fingertips

What are the Key Data Covered in this Thoracic Surgery Market Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the thoracic surgery market  between 2024 and 2028
  • Precise estimation of the thoracic surgery market size and its contribution to the market in focus on the parent market
  • Detailed analysis of customer landscape covering Diver of price sensitivity, Adoption of the lifecycle, and key purchase criteria 
  • Companies landscape comparing criticality of inputs and factors of differentiation
  • Exclusive Matrix on company's position and classification
  • Accurate predictions about upcoming trends and changes in consumer behavior
  • Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
  • A thorough analysis of the market’s competitive landscape and detailed information about companies
  • Comprehensive analysis of factors that will challenge the growth of thoracic surgery market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by End-user
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Product
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2023
    • 3.4 Market outlook: Forecast for 2023-2028
      • Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
      • Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

    4 Historic Market Size

    • 4.1 Global thoracic surgery market 2018 - 2022
      • Exhibit 18: Historic Market Size – Data Table on global thoracic surgery market 2018 - 2022 ($ million)
    • 4.2 End-user Segment Analysis 2018 - 2022
      • Exhibit 19: Historic Market Size – End-user Segment 2018 - 2022 ($ million)
    • 4.3 Product Segment Analysis 2018 - 2022
      • Exhibit 20: Historic Market Size – Product Segment 2018 - 2022 ($ million)
    • 4.4 Geography Segment Analysis 2018 - 2022
      • Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ million)
    • 4.5 Country Segment Analysis 2018 - 2022
      • Exhibit 22: Historic Market Size – Country Segment 2018 - 2022 ($ million)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

    6 Market Segmentation by End-user

    • 6.1 Market segments
      • Exhibit 30: Chart on End-user - Market share 2023-2028 (%)
      • Exhibit 31: Data Table on End-user - Market share 2023-2028 (%)
    • 6.2 Comparison by End-user
      • Exhibit 32: Chart on Comparison by End-user
      • Exhibit 33: Data Table on Comparison by End-user
    • 6.3 Hospitals - Market size and forecast 2023-2028
      • Exhibit 34: Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
      • Exhibit 35: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
      • Exhibit 36: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
      • Exhibit 37: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
    • 6.4 Ambulatory surgical centers - Market size and forecast 2023-2028
      • Exhibit 38: Chart on Ambulatory surgical centers - Market size and forecast 2023-2028 ($ million)
      • Exhibit 39: Data Table on Ambulatory surgical centers - Market size and forecast 2023-2028 ($ million)
      • Exhibit 40: Chart on Ambulatory surgical centers - Year-over-year growth 2023-2028 (%)
      • Exhibit 41: Data Table on Ambulatory surgical centers - Year-over-year growth 2023-2028 (%)
    • 6.5 Specialty clinics - Market size and forecast 2023-2028
      • Exhibit 42: Chart on Specialty clinics - Market size and forecast 2023-2028 ($ million)
      • Exhibit 43: Data Table on Specialty clinics - Market size and forecast 2023-2028 ($ million)
      • Exhibit 44: Chart on Specialty clinics - Year-over-year growth 2023-2028 (%)
      • Exhibit 45: Data Table on Specialty clinics - Year-over-year growth 2023-2028 (%)
    • 6.6 Market opportunity by End-user
      • Exhibit 46: Market opportunity by End-user ($ million)
      • Exhibit 47: Data Table on Market opportunity by End-user ($ million)

    7 Market Segmentation by Product

    • 7.1 Market segments
      • Exhibit 48: Chart on Product - Market share 2023-2028 (%)
      • Exhibit 49: Data Table on Product - Market share 2023-2028 (%)
    • 7.2 Comparison by Product
      • Exhibit 50: Chart on Comparison by Product
      • Exhibit 51: Data Table on Comparison by Product
    • 7.3 CRM and cardiac assist devices - Market size and forecast 2023-2028
      • Exhibit 52: Chart on CRM and cardiac assist devices - Market size and forecast 2023-2028 ($ million)
      • Exhibit 53: Data Table on CRM and cardiac assist devices - Market size and forecast 2023-2028 ($ million)
      • Exhibit 54: Chart on CRM and cardiac assist devices - Year-over-year growth 2023-2028 (%)
      • Exhibit 55: Data Table on CRM and cardiac assist devices - Year-over-year growth 2023-2028 (%)
    • 7.4 Heart valve repair and replacement devices - Market size and forecast 2023-2028
      • Exhibit 56: Chart on Heart valve repair and replacement devices - Market size and forecast 2023-2028 ($ million)
      • Exhibit 57: Data Table on Heart valve repair and replacement devices - Market size and forecast 2023-2028 ($ million)
      • Exhibit 58: Chart on Heart valve repair and replacement devices - Year-over-year growth 2023-2028 (%)
      • Exhibit 59: Data Table on Heart valve repair and replacement devices - Year-over-year growth 2023-2028 (%)
    • 7.5 Cardiopulmonary devices - Market size and forecast 2023-2028
      • Exhibit 60: Chart on Cardiopulmonary devices - Market size and forecast 2023-2028 ($ million)
      • Exhibit 61: Data Table on Cardiopulmonary devices - Market size and forecast 2023-2028 ($ million)
      • Exhibit 62: Chart on Cardiopulmonary devices - Year-over-year growth 2023-2028 (%)
      • Exhibit 63: Data Table on Cardiopulmonary devices - Year-over-year growth 2023-2028 (%)
    • 7.6 Heart defect closure devices - Market size and forecast 2023-2028
      • Exhibit 64: Chart on Heart defect closure devices - Market size and forecast 2023-2028 ($ million)
      • Exhibit 65: Data Table on Heart defect closure devices - Market size and forecast 2023-2028 ($ million)
      • Exhibit 66: Chart on Heart defect closure devices - Year-over-year growth 2023-2028 (%)
      • Exhibit 67: Data Table on Heart defect closure devices - Year-over-year growth 2023-2028 (%)
    • 7.7 Other thoracic surgery devices - Market size and forecast 2023-2028
      • Exhibit 68: Chart on Other thoracic surgery devices - Market size and forecast 2023-2028 ($ million)
      • Exhibit 69: Data Table on Other thoracic surgery devices - Market size and forecast 2023-2028 ($ million)
      • Exhibit 70: Chart on Other thoracic surgery devices - Year-over-year growth 2023-2028 (%)
      • Exhibit 71: Data Table on Other thoracic surgery devices - Year-over-year growth 2023-2028 (%)
    • 7.8 Market opportunity by Product
      • Exhibit 72: Market opportunity by Product ($ million)
      • Exhibit 73: Data Table on Market opportunity by Product ($ million)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 75: Chart on Market share by geography 2023-2028 (%)
      • Exhibit 76: Data Table on Market share by geography 2023-2028 (%)
    • 9.2 Geographic comparison
      • Exhibit 77: Chart on Geographic comparison
      • Exhibit 78: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2023-2028
      • Exhibit 79: Chart on North America - Market size and forecast 2023-2028 ($ million)
      • Exhibit 80: Data Table on North America - Market size and forecast 2023-2028 ($ million)
      • Exhibit 81: Chart on North America - Year-over-year growth 2023-2028 (%)
      • Exhibit 82: Data Table on North America - Year-over-year growth 2023-2028 (%)
    • 9.4 Europe - Market size and forecast 2023-2028
      • Exhibit 83: Chart on Europe - Market size and forecast 2023-2028 ($ million)
      • Exhibit 84: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
      • Exhibit 85: Chart on Europe - Year-over-year growth 2023-2028 (%)
      • Exhibit 86: Data Table on Europe - Year-over-year growth 2023-2028 (%)
    • 9.5 Asia - Market size and forecast 2023-2028
      • Exhibit 87: Chart on Asia - Market size and forecast 2023-2028 ($ million)
      • Exhibit 88: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
      • Exhibit 89: Chart on Asia - Year-over-year growth 2023-2028 (%)
      • Exhibit 90: Data Table on Asia - Year-over-year growth 2023-2028 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
      • Exhibit 91: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
      • Exhibit 92: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
      • Exhibit 93: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
      • Exhibit 94: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
    • 9.7 US - Market size and forecast 2023-2028
      • Exhibit 95: Chart on US - Market size and forecast 2023-2028 ($ million)
      • Exhibit 96: Data Table on US - Market size and forecast 2023-2028 ($ million)
      • Exhibit 97: Chart on US - Year-over-year growth 2023-2028 (%)
      • Exhibit 98: Data Table on US - Year-over-year growth 2023-2028 (%)
    • 9.8 Germany - Market size and forecast 2023-2028
      • Exhibit 99: Chart on Germany - Market size and forecast 2023-2028 ($ million)
      • Exhibit 100: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
      • Exhibit 101: Chart on Germany - Year-over-year growth 2023-2028 (%)
      • Exhibit 102: Data Table on Germany - Year-over-year growth 2023-2028 (%)
    • 9.9 France - Market size and forecast 2023-2028
      • Exhibit 103: Chart on France - Market size and forecast 2023-2028 ($ million)
      • Exhibit 104: Data Table on France - Market size and forecast 2023-2028 ($ million)
      • Exhibit 105: Chart on France - Year-over-year growth 2023-2028 (%)
      • Exhibit 106: Data Table on France - Year-over-year growth 2023-2028 (%)
    • 9.10 China - Market size and forecast 2023-2028
      • Exhibit 107: Chart on China - Market size and forecast 2023-2028 ($ million)
      • Exhibit 108: Data Table on China - Market size and forecast 2023-2028 ($ million)
      • Exhibit 109: Chart on China - Year-over-year growth 2023-2028 (%)
      • Exhibit 110: Data Table on China - Year-over-year growth 2023-2028 (%)
    • 9.11 Japan - Market size and forecast 2023-2028
      • Exhibit 111: Chart on Japan - Market size and forecast 2023-2028 ($ million)
      • Exhibit 112: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
      • Exhibit 113: Chart on Japan - Year-over-year growth 2023-2028 (%)
      • Exhibit 114: Data Table on Japan - Year-over-year growth 2023-2028 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 115: Market opportunity by geography ($ million)
      • Exhibit 116: Data Tables on Market opportunity by geography ($ million)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 117: Impact of drivers and challenges in 2023 and 2028
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 118: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 119: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 120: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 121: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 122: Matrix on vendor position and classification
            • 12.3 Abbott Laboratories
              • Exhibit 123: Abbott Laboratories - Overview
              • Exhibit 124: Abbott Laboratories - Business segments
              • Exhibit 125: Abbott Laboratories - Key news
              • Exhibit 126: Abbott Laboratories - Key offerings
              • Exhibit 127: Abbott Laboratories - Segment focus
            • 12.4 AbbVie Inc.
              • Exhibit 128: AbbVie Inc. - Overview
              • Exhibit 129: AbbVie Inc. - Product / Service
              • Exhibit 130: AbbVie Inc. - Key news
              • Exhibit 131: AbbVie Inc. - Key offerings
            • 12.5 Becton Dickinson and Co.
              • Exhibit 132: Becton Dickinson and Co. - Overview
              • Exhibit 133: Becton Dickinson and Co. - Business segments
              • Exhibit 134: Becton Dickinson and Co. - Key news
              • Exhibit 135: Becton Dickinson and Co. - Key offerings
              • Exhibit 136: Becton Dickinson and Co. - Segment focus
            • 12.6 Biosensors International Group Ltd.
              • Exhibit 137: Biosensors International Group Ltd. - Overview
              • Exhibit 138: Biosensors International Group Ltd. - Product / Service
              • Exhibit 139: Biosensors International Group Ltd. - Key offerings
            • 12.7 BioVentrix Inc.
              • Exhibit 140: BioVentrix Inc. - Overview
              • Exhibit 141: BioVentrix Inc. - Product / Service
              • Exhibit 142: BioVentrix Inc. - Key offerings
            • 12.8 Boston Scientific Corp.
              • Exhibit 143: Boston Scientific Corp. - Overview
              • Exhibit 144: Boston Scientific Corp. - Business segments
              • Exhibit 145: Boston Scientific Corp. - Key news
              • Exhibit 146: Boston Scientific Corp. - Key offerings
              • Exhibit 147: Boston Scientific Corp. - Segment focus
            • 12.9 Cardio Medical GmbH
              • Exhibit 148: Cardio Medical GmbH - Overview
              • Exhibit 149: Cardio Medical GmbH - Product / Service
              • Exhibit 150: Cardio Medical GmbH - Key offerings
            • 12.10 Edwards Lifesciences Corp.
              • Exhibit 151: Edwards Lifesciences Corp. - Overview
              • Exhibit 152: Edwards Lifesciences Corp. - Business segments
              • Exhibit 153: Edwards Lifesciences Corp. - Key offerings
              • Exhibit 154: Edwards Lifesciences Corp. - Segment focus
            • 12.11 GE Healthcare Technologies Inc.
              • Exhibit 155: GE Healthcare Technologies Inc. - Overview
              • Exhibit 156: GE Healthcare Technologies Inc. - Business segments
              • Exhibit 157: GE Healthcare Technologies Inc. - Key offerings
              • Exhibit 158: GE Healthcare Technologies Inc. - Segment focus
            • 12.12 Intuitive Surgical Inc.
              • Exhibit 159: Intuitive Surgical Inc. - Overview
              • Exhibit 160: Intuitive Surgical Inc. - Product / Service
              • Exhibit 161: Intuitive Surgical Inc. - Key offerings
            • 12.13 Johnson and Johnson
              • Exhibit 162: Johnson and Johnson - Overview
              • Exhibit 163: Johnson and Johnson - Business segments
              • Exhibit 164: Johnson and Johnson - Key news
              • Exhibit 165: Johnson and Johnson - Key offerings
              • Exhibit 166: Johnson and Johnson - Segment focus
            • 12.14 LivaNova Plc
              • Exhibit 167: LivaNova Plc - Overview
              • Exhibit 168: LivaNova Plc - Business segments
              • Exhibit 169: LivaNova Plc - Key offerings
              • Exhibit 170: LivaNova Plc - Segment focus
            • 12.15 Medtronic Plc
              • Exhibit 171: Medtronic Plc - Overview
              • Exhibit 172: Medtronic Plc - Business segments
              • Exhibit 173: Medtronic Plc - Key news
              • Exhibit 174: Medtronic Plc - Key offerings
              • Exhibit 175: Medtronic Plc - Segment focus
            • 12.16 Richard Wolf GmbH
              • Exhibit 176: Richard Wolf GmbH - Overview
              • Exhibit 177: Richard Wolf GmbH - Product / Service
              • Exhibit 178: Richard Wolf GmbH - Key offerings
            • 12.17 Teleflex Inc.
              • Exhibit 179: Teleflex Inc. - Overview
              • Exhibit 180: Teleflex Inc. - Business segments
              • Exhibit 181: Teleflex Inc. - Key news
              • Exhibit 182: Teleflex Inc. - Key offerings
              • Exhibit 183: Teleflex Inc. - Segment focus

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 184: Inclusions checklist
                • Exhibit 185: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 186: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 187: Research methodology
                • Exhibit 188: Validation techniques employed for market sizing
                • Exhibit 189: Information sources
              • 13.5 List of abbreviations
                • Exhibit 190: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              thoracic surgery market

              QUICK BUY

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis